Chargement en cours...
A potential role of ruxolitinib in leukemia
INTRODUCTION: An increased understanding of cellular signaling pathways, like the JAK--STAT pathway, and the identification of the JAK2 V617F mutation in the classic Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), has generated great interest in the development of targeted JAK2...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4143907/ https://ncbi.nlm.nih.gov/pubmed/21635221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.2011.589383 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|